Amniotic Membrane Market

Global Amniotic Membrane Market Outlook (2022 to 2032)

The global amniotic membrane market is estimated to hold a value of US$ 11.12 Bn in 2032 and is expected to expand at a CAGR of 14% during the forecast period from 2022 to 2032. Growth in the market can be attributed to the increasing cases of accidents and the rising awareness about the benefits offered provided by the amniotic membrane.

Report Attributes	Details
Estimated Market Value of the Global Amniotic Membrane in 2022	USD 3 Bn
Estimated Market Value of the Global Amniotic Membrane in 2032	USD 11.12 Bn
Projected CAGR from 2022 to 2032	14%
Key Players of the Global Amniotic Membrane Market	Alliqua BioMedical Inc. Amnio Technology LLC Applied Biologics LLC Human Regenerative Technologies LLC DermaSciences Katena Products Inc. MiMedx Group Inc. Skye Biologics Inc. Amniox Medical Inc. Integra LifeSciences Corporation

The advantages offered by the amniotic membranes, such as; their ability to reduce pain, can lead to the growing adoption of tissue-based products to heal surgical wounds. Furthermore, increasing expenditure in R&D in regenerative medicine and stem cells is expected to augment the market size in the forecast period.

Revenue Analysis of Global Amniotic Membrane Market 2015 to 2021 vs. Future Outlook 2022 to 2032

According to Fact.MR- a market research and competitive intelligence provider- the global amniotic membrane market surged at a CAGR of 12% from 2015 to 2021, securing a market value of US$ 2 Bn. The market is expected to grow owing to the increasing population of glaucoma patients.

The analysis at Fact.MR reveals that the market is likely to hold a market value of US$ 11.12 Bn in 2032. The expansion of the market can be attributed to the growing geriatric population, which has resulted in a rise in ophthalmology surgeries, posing a significant demand for these tissue-based products.

The outbreak of COVID-19 brought a negative impact on the market owing to the disruptions caused in the supply chain. Temporary halt in supply and manufacturing affected the market by restraining revenue generation. However, the key players are taking various initiatives to counter the challenges posed by the COVID-19 lockdown.

What are the Factors Boosting the Global Amniotic Membrane Market?

Increased Demand for Ophthalmology Amniotic Membrane to Boost the Market

The growing demand for these tissue-based products in ophthalmic surgeries due to their fast recovery properties is anticipated to play a significant role in driving the market during the forecast period. Moreover, the increasing demand for surgeries for aesthetic appeal is anticipated to boost the market.

As per the American Society of Plastic Surgeons, there were about 17.7 million cosmetics in 2018. Further, the growing prevalence of ocular disorders is expected to produce high demand for wound care techniques like amniotic membrane transplant, which is likely to expand the market during the forecast period.

A CDC report from 2019 reveals that there are approximately 1 million people in the U.S suffering from eye infections annually. In addition, the increasing initiative to improve the effectiveness of amniotic membranes is likely to bolster the growth of the market. For instance, Surgenex manufactured SurGraft, which is a dehydrated amniotic membrane providing a better shelf-life to enhance the longevity of the amniotic membrane.

What are the factors Hampering the global Amniotic Membrane Market?

High Amniotic Membrane Prices to Hamper the Market in the Forecast Period

The high amniotic membrane treatment costs is expected to hamper the market growth during the forecast period. Further, the risk of infections associated with the application of amniotic membrane is projected to affect the market negatively. As per a study published in Clinical Ophthalmology Journal in 2020, there is a higher risk of being infected with diseases such as; Hepatitis C, Hepatitis B, HIV, and Prion.

Besides, complications associated with amniotic membrane such as; the formation of Haemotomas, Granulomas, and Hypopon are other causes that can impede the market growth. In addition, the inadequate classification system for clinical conditions further inhibits the market expansion during the forecast period.

Country-Wise Analysis

What is the contribution of North America in driving the global amniotic membrane market?

Increasing Demand for Amniotic Eye Treatment to Boost the Market in North America

North America is anticipated to hold a significant market share during the forecast period owing to the increasing demand for amniotic eye treatment. The region is anticipated to have secured a revenue share of about 30% in 2022.

The growing focus to advance the healthcare sector, increasing awareness among the population about efficient alternative technologies are other salient causes augmenting the market in the forecast period.

Among all, the U.S is likely to make the most significant contribution in boosting the market in North America. The growing demand for ophthalmology amniotic eye treatment in the U.S is expected to be a salient cause augmenting the market size during the forecast period.

Why is Europe expected to be a Lucrative Market?

Increasing Chronic Diseases in Europe to Boost the Regional Market

The market in Europe is expected to secure the second-highest revenue share and is likely to exhibit a steady CAGR of 10% during the forecast period. The expansion of the market in Europe can be attributed to the adoption of universal health care systems, thereby growing the market in the region.

The W.H.O reveals that diseases such as diabetes, cancer, cardiovascular disease, chronic respiratory ailments claim about 86% of lives in the region. Therefore, there has been a significant rise in demand for efficient methods to reduce the fatalities and counter dieses, thereby expanding the market in the region.

Category-Wise Insights

By End-Use, which Category is likely to Impel Demand for Amniotic Membrane?

Rising Application of Amniotic Membranes in ASCs to Boost the Hospital Segment

Based on end-use, the market is anticipated to be dominated by the hospital segment during the forecast period. As per the assessment at Fact.MR, the segment is expected to secure about 38% of the market share in 2022.

The growth of the segment can be attributed to the increasing number of visits by patients to the hospital to procure primary health care facilities. Escalating usage of amniotic membranes in ASCs is expected to be another salient factor boosting the market expansion in the coming time. In addition, the ease to use the medical equipment is projected to support the segment growth in the forthcoming time.

Which Application Area is forecast to Yield Maximum Returns?

Surgical Wounds to comprise bulk of Amniotic Membranes Deployment

Based on application, the market can be segmented into surgical wounds, ophthalmology, and others. As per the estimations at Fact.MR, the surgical wounds segment is expected to procure the largest revenue share of about 36%.

The expansion of the segment can be attributed to the increasing incidences of infectious and chronic diseases. These equipment are used in ophthalmic surgeries for fast recovery and to lessen inflammation. In addition, the growing number of surgeries to enhance the aesthetic appeal is predicted to further expand the market size in the forecast period.

Competitive Landscape

The global players of the amniotic membrane market adopt various strategies to enhance their global reach and secure the forefront position in the market. Partnership, acquisitions, and collaboration are some of the most adopted approaches to expand their market footprint. Some of the recent developments among the key players are:

• In July 2022, Merakris Therapeutics launched Dermacyte Matrix. It is an amniotic membrane used for the protection and repair of damaged tissues.
• In February 2022, TissueTech, a renowned name in the clinical application of cryopreserved human birth tissue products to treat chronic wounds, ocular surface disorders, and musculoskeletal conditions, disclosed its new name and a new logo. BioTissue, Inc and Amniox Medical, Inc. will both be known under a single entity called, BioTissue, Inc.
• In December 2021, Audax Private Equity disclosed that it had successfully completed the sale of Katena Products to Corza Medical. Corza Medical is a GTCR portfolio company. Katena is a renowned entity offering ophthalmic devices and therapeutics to hospitals, surgical centers, and clinics.

Amniotic Membrane Market Report Scope

Attribute	Details
Forecast Period	2022-2032
Historical Data	2015-2021
Key Regions Covered	North America MEA Latin America Europe Asia-Pacific
Key Countries Covered	U.S Canada Brazil Mexico Germany France U.K Italy BENELUX Nordics China Japan South Korea GCC South Africa Turkey
Key Segments Covered	End Use Product Application Region

Key Market Segments Covered in the Global Amniotic Membrane Market

• By Product

  • Cryopreserved Amniotic Membrane
  • Dehydrated Amniotic Membrane

• By Application

  • Amniotic Membrane for Surgical Wounds
  • Amniotic Membrane for Ophthalmology
  • Amniotic Membrane for Other Applications

• By End Use

  • Amniotic Membrane for Hospitals
  • Amniotic Membrane for Ambulatory Surgical Centers
  • Amniotic Membrane for Specialty Clinics
  • Amniotic Membrane for Academic & Research Institutes